v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (in shares) 47,594,930  
Beginning balance $ (4,825) $ (130,328)
Common stock withheld for taxes   (4)
Stock-based compensation 64 196
Net income (loss) $ (2,658) 4,020
Ending balance (in shares) 47,602,790  
Ending balance $ (7,419) $ (126,116)
Common Stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (in shares) 47,594,930 47,556,267
Beginning balance $ 482 $ 475
Issuance of common stock for restricted stock units (in shares) 7,860 7,499
Common stock withheld for taxes, (in shares)   (2,814)
Ending balance (in shares) 47,602,790 47,560,952
Ending balance $ 482 $ 475
Common To Be Issued    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (in shares) 2,701 2,701
Beginning balance $ 0 $ 0
Ending balance (in shares) 2,701 2,701
Ending balance $ 0 $ 0
Additional Paid-in Capital    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance 349,198 348,560
Common stock withheld for taxes   (4)
Stock-based compensation 64 196
Ending balance 349,262 348,752
Accumulated Deficit    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Beginning balance (354,505) (479,363)
Net income (loss) (2,658) 4,020
Ending balance $ (357,163) $ (475,343)